Insights & Resources – COD Research – Designing Therapies For Future

The Evolution of PRO Collection: From Paper Diaries to ePRO Systems

Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial

Biometrics

Clinical Services

CT Quality Assurance

Medical Affairs

Strategic Planning for Patient Recruitment

EMA
FDA
MHRA

Quarterly System Demo - Q4 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 December 2026, 09:00 (CET) to 10 December 2026, 12:30 (CET)
Source: EMA Published on 2026-10-28
Notice to sponsors on validation and qualification of computerised systems used in clinical trials
Source: EMA Published on 2026-10-28
Human medicines European public assessment report (EPAR): Dazparda, insulin aspart, Date of authorisation: 27/04/2026, Revision: 1, Status: Authorised
Source: EMA Published on 2026-10-28
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 16 November 2027, 09:30 (CET) to 16 November 2027, 13:30 (CET)
Source: EMA Published on 2026-10-28
Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party, Online, from 7 December 2027, 09:30 (CET) to 7 December 2027, 13:30 (CET)
Source: EMA Published on 2026-10-28
Medicine Shortages SPOC Working Party meetings
Source: EMA Published on 2026-10-28

Read More